InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,427.95
(
0.88%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

lefty18

Send PM Follow Ignore
Followers 43
Posts 3041
Boards Moderated 1
Alias Born 08/09/2006

lefty18

Re: None

Monday, 12/14/2009 7:08:14 PM

Monday, December 14, 2009 7:08:14 PM

Post# of 97239
TGEN's stock is moving on the $7,000,000 deal with Genzyme. Genzyme will pay a total of $7 mil to use TGEN's AAV technology, and royalties if any drugs are approved using the technology. TGEN also has a royalty deal with Celladon and three clinical programs in process using their gene therapy technology.


Only the beginning.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up